Acyclovir Dosage and Treatment for Viral Eye Infections

Introduction to Acyclovir Treatment

• The American Academy of Ophthalmology recommends oral acyclovir dosed at 400 mg five times daily for 7-10 days for herpes simplex virus (HSV) ocular infections, with higher doses of 800 mg five times daily for severe or resistant cases 1
• Standard oral dosing for HSV ocular disease is 200-400 mg five times daily, with the higher 400 mg dose demonstrating equivalent efficacy to topical antiviral therapy in clinical trials 1

HSV Conjunctivitis and Keratitis Treatment

• For HSV keratitis, the recommended oral regimen is acyclovir 200-400 mg five times daily 1
• Treatment duration should be 7-10 days for acute episodes 1
• Higher doses of 800 mg five times daily should be considered for cases demonstrating resistance to standard therapy or in immunocompromised patients 1

HSV Uveitis Treatment

• For HSV uveitis flare-ups, valacyclovir 500 mg two to three times daily for 7-10 days is the preferred oral antiviral, as it provides superior bioavailability compared to acyclovir 2

Varicella Zoster Virus (VZV) Ocular Infections Treatment

• For VZV conjunctivitis and keratitis in immunocompetent patients with persistent or recalcitrant disease, acyclovir 800 mg five times daily for 7 days is recommended 1

Severe or Complicated Cases Management

• For acute retinal necrosis, initial therapy requires intravenous acyclovir 10 mg/kg three times daily for 10-14 days, followed by oral therapy with either valacyclovir 1 g three times daily for 4-6 weeks or acyclovir 20 mg/kg for 4-6 weeks 3, 4, 5

Critical Management Considerations

• Topical corticosteroids must be avoided in HSV epithelial infections as they potentiate viral replication, but may be used in conjunction with oral antivirals for HSV stromal keratitis 1, 2
• Follow-up within 1 week is essential, including visual acuity measurement and slit-lamp biomicroscopy 1, 2
• Oral antivirals alone may not adequately prevent progression of HSV blepharoconjunctivitis; adding topical antiviral treatment improves outcomes 1

Long-term Prophylaxis

• Lower doses of oral antivirals are used for long-term prophylaxis against recurrent HSV keratitis, though specific dosing should be adjusted based on clinical response 1, 2

Special Populations

• Neonates with HSV ocular infection require immediate pediatric consultation due to risk of life-threatening systemic infection 1, 2
• Immunocompromised patients may require more aggressive dosing and should be monitored for renal toxicity 2